Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dukor

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1975
Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement systemD Bitter-Suermann, U Hadding, H U Schorlemmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1989
Origin and fate of IgE-bearing lymphocytes. II. Modulation of IgE isotype expression on Peyer's patch cells by feeding with certain bacteria and bacterial cell wall components or by thymectomyH G Durkin, S M Chice, E Gaetjens, et al.
Clinical and Experimental Immunology|November 1, 1992
Selection of a muramyl peptide based on its lack of activation of nuclear factor-kappa B as a potential adjuvant for AIDS vaccinesR Schreck, D Bevec, P Dukor, et al.
Clinical Immunology and Immunopathology|March 1, 1993
Control of IgE responses. III. IL-6 and IFN-alpha are isotype-specific regulators of peak BPO-specific IgE antibody-forming cell responses in miceD L Auci, G I Kleiner, S M Chice, et al.
British Medical Journal|April 22, 1972
Excretion of urinary casts after the administration of diureticsP R Imhof, J Hushak, G Schumann, et al.
Immunopharmacology|April 1, 1997
Suppression of in vivo IgE and tissue IL-4 mRNA induction by SDZ 280.636, a synthetic muramyl dipeptide derivativeF Kricek, M Zunic, C Ruf, et al.
Cellular Immunology|April 1, 1978
Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components) in vitroF G Staber, R H Gisler, G Schumann, et al.
International Immunology|July 1, 1995
IgG isotype-specific auto-antibodies bind preferentially to cross-linked membrane IgG Fazekas, G Pálfi, B Wolff-Winiski, et al.
International Archives of Allergy and Immunology|January 1, 1993
Control of IgE responses. 4. Isotype-specific suppression of peak BPO-specific IgE antibody-forming cell responses and of BPO-specific IgE in serum by muramyldipeptide or murabutide after administration to mice by gavageD L Auci, J A Carucci, S M Chice, et al.
The Journal of Experimental Medicine|February 1, 1974
Complement-dependent B-cell activation by cobra venom factor and other mitogens?P Dukor, G Schumann, R H Gisler, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1975
Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement systemD Bitter-Suermann, U Hadding, H U Schorlemmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1989
Origin and fate of IgE-bearing lymphocytes. II. Modulation of IgE isotype expression on Peyer's patch cells by feeding with certain bacteria and bacterial cell wall components or by thymectomyH G Durkin, S M Chice, E Gaetjens, et al.
Clinical and Experimental Immunology|November 1, 1992
Selection of a muramyl peptide based on its lack of activation of nuclear factor-kappa B as a potential adjuvant for AIDS vaccinesR Schreck, D Bevec, P Dukor, et al.
Clinical Immunology and Immunopathology|March 1, 1993
Control of IgE responses. III. IL-6 and IFN-alpha are isotype-specific regulators of peak BPO-specific IgE antibody-forming cell responses in miceD L Auci, G I Kleiner, S M Chice, et al.
British Medical Journal|April 22, 1972
Excretion of urinary casts after the administration of diureticsP R Imhof, J Hushak, G Schumann, et al.
Immunopharmacology|April 1, 1997
Suppression of in vivo IgE and tissue IL-4 mRNA induction by SDZ 280.636, a synthetic muramyl dipeptide derivativeF Kricek, M Zunic, C Ruf, et al.
Cellular Immunology|April 1, 1978
Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components) in vitroF G Staber, R H Gisler, G Schumann, et al.
International Immunology|July 1, 1995
IgG isotype-specific auto-antibodies bind preferentially to cross-linked membrane IgG Fazekas, G Pálfi, B Wolff-Winiski, et al.
International Archives of Allergy and Immunology|January 1, 1993
Control of IgE responses. 4. Isotype-specific suppression of peak BPO-specific IgE antibody-forming cell responses and of BPO-specific IgE in serum by muramyldipeptide or murabutide after administration to mice by gavageD L Auci, J A Carucci, S M Chice, et al.
The Journal of Experimental Medicine|February 1, 1974
Complement-dependent B-cell activation by cobra venom factor and other mitogens?P Dukor, G Schumann, R H Gisler, et al.
Pageof 5